Tirzepatide injection pen used to improve blood sugar control in type 2 diabetes. 15 mg dose.
Contains tirzepatide, a dual GIP/GLP-1 receptor agonist. Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Attributes
Product Content
How to Use:
• Inject subcutaneously once weekly in the abdomen, thigh, or upper arm, any time of day, with or without food.
• Starting dose is 2.5 mg weekly for 4 weeks (not a maintenance dose).
• Increase in 2.5 mg increments every 4+ weeks as needed, up to a maximum of 15 mg weekly.
• Rotate injection sites with each dose.
The link to Mounjaro KwikPen 15mg 1 Prefilled Pen (Refrigerated) has been copied